General Information
| Application | Inhibitor |
|---|
| Description | Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. |
|---|
| Cas NO. | 1448232-80-1 |
|---|
| Purity | ≥98% |
|---|---|
| Molecular Weight | 562.71 |
| Formula | C30H42N8O3 |
| Solubility |
DMSO : 52 mg/mL Ethanol : 100 mg/mL Water : Insoluble |
|---|
| Alias | N/A |
|---|
| Target / IC50 |
mutant EGFR |
|---|
| Storage |
Powder : -20°C for 3 years |
|---|
|
|
1 mg |
5 mg |
10 mg |
|
|
1 mM |
1.7771 mL | 8.8856 mL | 17.7711 mL | |
| 5 mM | 0.3554 mL | 1.7771 mL | 3.5542 mL | |
| 10 mM | 0.1777 mL | 0.8886 mL | 1.7771 mL | |
.png)